Skip to main content

Department of Health Policy Archives

Innovative strategies crucial in opioid epidemic response

Sep. 27, 2018—Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.

Read more


Health policy speaker urges looking beyond data

Sep. 6, 2018—Katherine Swartz, PhD, a nationally known leader in health policy research, encouraged others conducting investigations in the field to move beyond the data and into local communities to gather the stories behind the data during last week’s Research into Policy and Practice Lecture hosted by Vanderbilt University Medical Center’s Department of Health Policy.

Read more


Vanderbilt study explores how dual-eligible beneficiaries spend

Aug. 16, 2018—While there has been much effort to control spending for individuals eligible for both Medicaid and Medicare in the United States, for the first time a team of Vanderbilt health policy researchers have analyzed spending trends for this population over a multiyear period in order to gain a much clearer understanding of exactly how much is being spent and by whom.

Read more


Study to explore how rising medication costs impact elderly

Aug. 9, 2018—As both drug prices and out-of-pocket expense for prescription medications continue to climb, a team of Health Policy experts at Vanderbilt University School of Medicine (VUSM) have received a grant to determine if these factors are causing older Americans enrolled in Medicare Part D for medication coverage to delay or never fill their prescriptions.

Read more


Team Hope program’s mission is to enhance care for newborns with NAS

Jul. 26, 2018—A collaborative program across units at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt is changing the way nurses and doctors care for newborns diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS).

Read more


Integrated, multidisciplinary approach key to opioid fight: panel

Jul. 26, 2018—No single approach will end the epidemic of fatal overdoses caused by addiction to opioid painkillers and heroin that is ravaging this country, the U.S. Assistant Secretary for Health, Adm. Brett Giroir, MD, warned Tuesday during a panel discussion in a packed lecture hall at Vanderbilt University Medical Center.

Read more


Study shows legalizing same-sex marriage increased care access

Jul. 19, 2018—Vanderbilt researchers have documented evidence that legalizing same-sex marriage has improved access to health care for gay men in a study released as a National Bureau of Economic Research working paper this week.

Read more


Buntin visits the Hill

Jul. 12, 2018—Melinda Buntin, PhD, Mike Curb Professor and Chair of the Department of Health Policy, recently testified before the Senate Health, Education, Labor and Pensions Committee chaired by U.S. Sen. Lamar Alexander.

Read more


Study reveals opioid patients face multiple barriers to treatment

Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Read more


Addressing the opioid crisis

May. 24, 2018—U.S. Surgeon General Jerome Adams, MD, MPH, visited Vanderbilt University Medical Center last week to speak at the spring Health Policy Grand Rounds at Langford Auditorium. The event was dedicated to combatting America’s opioid crisis, and Adams emphasized the importance of the overdose-reversal drug naloxone.

Read more


Early discharge of NAS infants prolongs treatment

May. 17, 2018—Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study.

Read more


Study finds generic options offer limited savings for expensive drugs

May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.

Read more


Page 1 of 512345

Recent Stories from VUMC News and Communications Publications

Our amazing skin

Vanderbilt Medicine

Our amazing skin

Biology and the beat

Vanderbilt Medicine

Biology and the beat

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

more